Susquehanna International Group
MREO

Susquehanna International Group’s Mereo BioPharma MREO Stock Holding History

Susquehanna International Group’s Portfolio MREO Stock Details MREO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$64.7K Buy
+195,920
New +$84.1K ﹤0.01% 12547
2025
Q4 		– Sell
-493,378
Closed -$939K – 13132
2025
Q3 		$1.02M Buy
493,378
+131,836
+36% +$243K ﹤0.01% 7323
2025
Q2 		$980K Buy
361,542
+187,164
+107% +$452K ﹤0.01% 7485
2025
Q1 		$392K Sell
174,378
-217,212
-55% -$614K ﹤0.01% 9442
2024
Q4 		$1.37M Buy
391,590
+5,160
+1% +$20.3K ﹤0.01% 6177
2024
Q3 		$1.59M Sell
386,430
-453,834
-54% -$1.88M ﹤0.01% 5768
2024
Q2 		$3.02M Sell
840,264
-779,363
-48% -$2.52M ﹤0.01% 4288
2024
Q1 		$5.34M Buy
1,619,627
+1,443,999
+822% +$4.89M ﹤0.01% 3535
2023
Q4 		$406K Buy
175,628
+72,358
+70% +$138K ﹤0.01% 9153
2023
Q3 		$133K Buy
+103,270
New +$137K ﹤0.01% 10673
2023
Q2 		– Sell
-43,089
Closed -$50K – 12743
2023
Q1 		$30.5K Buy
43,089
+29,989
+229% +$27K ﹤0.01% 11903
2022
Q4 		$9.82K Sell
13,100
-38,825
-75% -$31.9K ﹤0.01% 11939
2022
Q3 		$45K Sell
51,925
-15,154
-23% -$18.5K ﹤0.01% 12269
2022
Q2 		$75K Buy
+67,079
New +$52K ﹤0.01% 11718
2022
Q1 		– Sell
-61,937
Closed -$80.1K – 13614
2021
Q4 		$99K Buy
61,937
+23,355
+61% +$46.7K ﹤0.01% 12159
2021
Q3 		$93K Buy
38,582
+17,453
+83% +$46.2K ﹤0.01% 12106
2021
Q2 		$67K Buy
21,129
+5,175
+32% +$17.4K ﹤0.01% 12234
2021
Q1 		$54K Buy
+15,954
New +$56.4K ﹤0.01% 12016

Other funds holding MREO

RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
DCM
Defilade Capital Management Emeryville, California $712M AUM
NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
TC
Tejara Capital London, United Kingdom $303M AUM 5.43% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
WANY
Wealthspire Advisors (New York) New York $12.7B AUM 17.31% 1-Year Est. Return

Susquehanna International Group's MREO Position: Q1 2026 in Review

Susquehanna International Group opened a new position in Mereo BioPharma (MREO) in Q1 2026: 195,920 shares worth $64.7K. The stake represents ﹤0.01% of the portfolio and ranks #12547 among its holdings. This is a return to the name: Susquehanna International Group previously reported a position in MREO as recently as Q3 2025.

Susquehanna International Group first reported a position in MREO in Q1 2021 and has held it in 18 quarters since. The position peaked at $5.34M in Q1 2024. 63 funds tracked by Wall St. Rank hold MREO as of Q1 2026.

  • Susquehanna International Group held 195,920 shares of Mereo BioPharma worth $64.7K as of Q1 2026.
  • Mereo BioPharma was a new Susquehanna International Group position in Q1 2026.
  • Mereo BioPharma made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #12547 holding.
  • Susquehanna International Group first reported a position in Mereo BioPharma in Q1 2021 and has held it in 18 quarters since.
  • Susquehanna International Group's Mereo BioPharma position peaked at $5.34M in Q1 2024.
  • 63 funds tracked by Wall St. Rank held Mereo BioPharma as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.